Список литературы к статье "Метаанализ применения ацетил-L-карнитина при диабетическом периферическом нейропатии"

Статьи

Текст статьи

Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973 // Diabetes Care. 1978. Vol. 1. P. 252-263.
Benbow S.J., Wallymahmed M.E., MacFarlane I. Diabetic peripheral neuropathy and quality of life // QJM. 1998. Vol. 91. P. 733-737.
Boulton A.J.M. Treatments for diabetic neuropathy // Curr Diab Rep. 2001. Vol. 1. P. 127- 132.
Griebeler M.L., Tsapas A., Brito J.P. et al. Pharmacologic interventions for painful diabetic neuropathy: an umbrella systematic review and comparative effectiveness network meta-analysis (Protocol) // Syst Rev. 2012. Vol. 1. P. 61.
Faradji V., Sotelo J. Low serum levels of nerve growth factor in diabetic neuropathy // Acta Neurol Scand. 1990. Vol. 81. P. 402-406.
Levine J., Panchalingam K., McClure R.J. et al. Effects of acetyl-L-carnitine and myoinositol on high-energy phosphate and membrane phospholipid metabolism in zebra fish: a 31P-NMR-spectroscopy study // Neurochem Res. 2003. Vol. 28. P. 687-690.
Traina G., Federighi G., Macchi M. et al. Modulation of myelin basic protein gene expression by acetyl-L-carnitine // Mol Neurobiol. 2011. Vol. 44. P. 1-6.
Vivoli E., Di Cesare Mannelli L., Salvicchi A. et al. Acetyl-l-carnitine increases artemin level and prevents neurotrophic factor alterations during neuropathy // Neuroscience. 2010. Vol. 167. P. 1168-1174.
Vanotti A., Osio M., Mailland E. et al. Overview on pathophysiology and newer approaches to treatment of peripheral neuropathies // CNS Drugs. 2007. Vol. 21(1). P. 3-12.
Traina G. The neurobiology of acetyl-L-carnitine. Front Biosci (Landmark Ed). 2016. Vol. 21. P. 1314-1329.
Ido Y., McHowat J., Chang K.C. et al. Neural dysfunction and metabolic imbalances in diabetic rats: prevention by acetyl-L-carnitine // Diabetes. 1994. Vol. 43. P. 1469-1477.
Chiechio S., Copani A., Iv R.W.G., Nicoletti F. Acetyl-L-carnitine in neuropathic pain // CNS Drugs. 2007. Vol. 21(1). P. 31-38.
Malaguarnera M. Carnitine derivatives: clinical usefulness // Curr Opin Gastroenterol. 2012. Vol. 28. P. 166-176.
Watson J.C., Dyck P.J.B. Peripheral neuropathy: a practical approach to diagnosis and symptom management // Mayo Clin Proc. 2015. Vol. 90. P. 940-951.
Li S., Li Q., Li Y. et al. Acetyl-L-carnitine in the treatment of peripheral neuropathic pain: a systematic review and meta-analysis of randomized controlled trials // Plos One. 2015. Vol. 10. P. 1-10.
Liberati A., Altman D.G., Tetzlaff J. et al. The Prisma statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration // Plos Med. 2009. Vol. 6. P. e1000100.
Stroup D.F., Berlin J., Morton S.C. et al. Metaanalysis of observational studies in epidemiology: a proposal for reporting // JAMA. 2000. Vol. 283. P. 2008-2012.
Jadad A.R. The merits of measuring the quality of clinical trials: is it becoming a Byzantine discussion? // Transpl Int. 2009. Vol. 22. P. 1028.
Jadad A.R., Moore R.A., Carroll D. et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? // Control Clin Trials. 1996. Vol. 17. P. 1-12.
DerSimonian R., Laird N. Meta-analysis in clinical trials // Control Clin Trials. 1986. Vol. 7. Р. 177-188.
Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test // BMJ. 1997. Vol. 315. P. 629-634.
Cakir N., Yctkin I., Karakoc A., Karakan T. L-Carnitine in the treatment of painful diabetic neuropathy and its effect on plasma 3-endorphin levels // Current Therapeutic Research. 2000. Vol. 61. P. 871-876.
De Grandis D., Minardi C. Acetyl-L-carnitine (levacarnine) in the treatment of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled study // Drugs R D. 2002.Vol. 3. P. 223-231.
Li S., Chen X., Li Q.Q. et al. Effects of acetyl-L-carnitine and methylcobalamin for diabetic peripheral neuropathy: a multicenter, randomized, double-blinded, controlled trial // J Diabetes Investig. 2016. Vol. 7(5). P. 777-785.
Sima A., Calvani M., Mehra M., Amato A. Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials // Diabetes Care. 2005. Vol. 28. P. 89-94.
Ulvi H., Aygu"l R., Demir R. Effect of L-carnitine on diabetic neuropathy and ventricular dispersion in patients with diabetes mellitus // Turkish J Med Sci. 2010. Vol. 40. P. 169-175.
Uzun N., Sarikaya S., Uluduz D., Aydin A. Peripheric and automatic neuropathy in children with type 1 diabetes mellitus: the effect of L-carnitine treatment on the peripheral and autonomic nervous system // Electromyogr Clin Neurophysiol. 2005. Vol. 45. P. 343-351.
Onofrj M., Ciccocioppo F., Varanese S. et al. Acetyl-L-carnitine: from a biological curiosity to a drug for the peripheral nervous system and beyond // Expert Rev Neurother. 2013. Vol. 13. P. 925-936.
Anjaneyulu M., Berent-Spillson A., Russell J.W. Metabotropic glutamate receptors (mGluRs) and diabetic neuropathy // Curr Drug Targets. 2008. Vol. 9. P. 85-93.
Davalli A.M., Perego C., Folli F.B. The potential role of glutamate in the current diabetes epidemic // Acta Diabetol. 2012. Vol. 49. P. 167-183.
Aminoff M.J. Clinical Electromyography // Electrodiagnosis in Clinical Neurology. 2005. P. 233-259.
Taglialatela G., Navarra D., Cruciani R. et al. Acetyl-L-carnitine treatment increases nerve growth factor levels and choline acetyltransferase activity in the central nervous system of aged rats // Exp Gerontol. 1994. Vol. 29. P. 55-66.

22 июня 2017 г.

Список литературы к статье "Метаанализ применения ацетил-L-карнитина при диабетическом периферическом нейропатии"

Комментарии